Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended February 28, 2022, including the related management’s discussion and analysis and CEO and CFO … [Read more…]
